Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K253682

DeepHealth ProstateAI

Quantib B.V.

Authorized purpose: Concurrent-reading aid for trained physicians detecting and characterizing prostate-cancer lesions in adult males aged 40 years and older undergoing prostate MRI.

Modality
MRI
Anatomy
Prostate and lesions within or extending from the prostate
Decision
2026-04-29
FDA-cleared K253780

SIGNA™ Bolt

Ge Medical Systems, LLC

Authorized purpose: SIGNA Bolt is a whole-body MRI system for high-resolution diagnostic imaging of the labeled body regions, with supported AI-assisted reconstruction, positioning, and protocol functions.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal anatomy
Decision
2026-02-06
FDA-cleared K253779

SIGNA™ Sprint Select

Ge Medical Systems, LLC

Authorized purpose: SIGNA Sprint Select is a whole-body MRI system for diagnostic imaging of the labeled body regions, with supported AI-assisted reconstruction, positioning, and protocol functions.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal anatomy
Decision
2026-02-05
FDA-cleared K253091

ART-Plan+ (v3.1.0)

Therapanacea Sas

Authorized purpose: ART-Plan+ assists trained radiation-therapy professionals with multimodal image review, registration, contouring, and the release-specific planning functions described in K253091. This release combined Annotate, prostate SmartPlan, and AdaptBox for supported head-and-neck, breast or thorax, and male-pelvis offline adaptive workflows, and added structures without changing the core indication.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2025-12-23
FDA-cleared K251399

SIGNA™ Sprint

GE Medical Systems, LLC

Authorized purpose: SIGNA Sprint is a 1.5T whole-body MRI system for diagnostic imaging of the labeled head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal regions.

Modality
MRI
Anatomy
Head; neck; temporomandibular joint; spine; breast; heart; abdomen; pelvis; joints; prostate; vessels; and musculoskeletal anatomy
Decision
2025-09-11
FDA-cleared K250064

Dose+ (1.0)

Mvision AI Oy

Authorized purpose: Dose+ 1.0 uses locked machine-learning models to predict a patient-specific three-dimensional dose distribution for men receiving external-beam radiotherapy for localized prostate cancer or prostate cancer with pelvic-node involvement. Qualified users must review its DICOM RT Dose output in a treatment-planning system or compatible viewer.

Modality
Radiotherapy Planning Imaging
Anatomy
Prostate/Pelvis
Decision
2025-09-04
FDA-cleared K242683

QP-Prostate® CAD

Quibim S.L.

Authorized purpose: QP-Prostate CAD detects and marks suspected prostate lesions for clinically significant prostate cancer on bi-parametric T2-weighted and diffusion-weighted prostate MRI, returning moderate/high suspicion overlays in DICOM to third-party workstations/PACS for concurrent physician review; patient management must not rely on it alone.

Modality
MRI
Anatomy
Prostate
Decision
2025-03-18
FDA-cleared K250379

SIGNA Prime Elite

GE Medical Systems, LLC

Authorized purpose: SIGNA Prime Elite is a whole-body MR system that produces cross-sectional, spectroscopic, parametric, and dynamic images of the labeled body regions for trained physician interpretation, with contrast use depending on the region and protocol.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, vessels, and musculoskeletal anatomy
Decision
2025-03-17
FDA-cleared K241770

Prostate MR AI (VA10A)

Siemens Healthcare GmbH

Authorized purpose: Prostate MR AI (VA10A) is a plug-in CADe/CADx aid for radiologists interpreting prostate MRI in adult men aged 40 years or older with suspected prostate cancer and no prior treatment, using PI-RADS-oriented review; it is not the sole basis for diagnosis or management.

Modality
MRI
Anatomy
Prostate
Decision
2025-03-05
FDA-cleared K242822

ART-Plan+ (v.3.0.0)

Therapanacea SAS

Authorized purpose: ART-Plan assists trained radiation-therapy professionals with multimodal image review, registration, contouring, and the release-specific planning functions described in K242822. This release included Annotate and TumorBox contouring plus SmartPlan automatic prostate-plan generation for import into the treatment-planning system for dose calculation, review, and approval.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2025-02-25
FDA-cleared K250035

Contour ProtégéAI+

MIM Software Inc.

Authorized purpose: Contour ProtégéAI+ automatically creates contours on CT and T2 MR DICOM images as an accessory to MIM software for quantitative analysis, adaptive therapy, transfer, and archive; users must review and edit contours, and the device is not intended to detect or contour lesions.

Modality
Radiotherapy Planning Imaging
Anatomy
CT anatomical regions; prostate, seminal vesicles, and urethra on T2 MR
Decision
2025-02-03
FDA-cleared K233196

Medihub Prostate

JLK Inc.

Authorized purpose: Assist trained radiologists and urologists in reviewing and analyzing prostate MR studies through semi-automatic prostate outlining, multiparametric visualization, and related measurements and reporting; patient-management decisions must not rely on the software alone.

Modality
MRI
Anatomy
Prostate
Decision
2024-06-21
FDA-cleared K233728

SIGNA Champion

GE Healthcare (Tianjin) Company Limited

Authorized purpose: The SIGNA Champion is a whole-body magnetic resonance scanner indicated to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, spectra, and dynamic images of structures or functions of the body for trained-physician interpretation that may assist diagnosis. Contrast agents may be used depending on the region.

Modality
MRI
Anatomy
Head, neck, temporomandibular joint, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions of the body
Decision
2024-01-19
FDA-cleared K233568

Ceevra Reveal 3+

Ceevra, Inc.

Authorized purpose: Process, review, analyze, communicate, and exchange multidimensional CT or MR images, including preliminary segmentation of normal anatomy, for preoperative surgical planning and intraoperative display; healthcare professionals make all final patient-management decisions. Machine-learning algorithms are for adults aged 22 years and older, while images for patients under 22 or of unknown age are generated without machine learning.

Modality
CT/CTA; MRI
Anatomy
Multi-region normal anatomy represented in CT or MR images; validated examples include prostate, bladder, neurovascular bundles, kidney, artery, and vein
Decision
2023-12-05
FDA-cleared K231765

Contour ProtégéAI

MIM Software Inc.

Authorized purpose: Contour ProtegeAI assists trained medical professionals with automated processing of CT and MR images, creates machine-learning contours for quantitative analysis, adaptive therapy, transfer to radiation-treatment planning systems, and archiving, segments structures across CT locations, and segments the prostate, seminal vesicles, and urethra on T2-weighted MR images.

Modality
Radiotherapy Planning Imaging
Anatomy
CT anatomic locations and the prostate, seminal vesicles, and urethra on T2-weighted MR
Decision
2023-11-08
FDA-cleared K223623

SubtleMR (2.3.x)

Subtle Medical Inc.

Authorized purpose: MRI image enhancement by reducing image noise for head, spine, neck, abdomen, pelvis, prostate, breast, and musculoskeletal MRI, or increasing image sharpness for head MRI.

Modality
MRI
Anatomy
Head, spine, neck, abdomen, pelvis, prostate, breast, and musculoskeletal regions
Decision
2023-05-11
FDA-cleared K230772

Quantib Prostate

Quantib BV

Authorized purpose: Support trained medical professionals in processing, visualizing, editing, and interpreting prostate MR studies, including structured PI-RADS scoring; diagnosis must not be made solely from the software analysis.

Modality
MRI
Anatomy
Prostate, prostatic sub-regions, and user-selected potential lesions.
Decision
2023-04-17
FDA-cleared K223774

Contour ProtégéAI

MIM Software Inc.

Authorized purpose: Contour ProtegeAI assists trained medical professionals with automated processing of CT and MR images, machine-learning contour creation for quantitative analysis, adaptive therapy, transfer to radiation-treatment planning systems, and archiving, segmentation across CT locations, and segmentation of the prostate, seminal vesicles, and urethra on T2-weighted MR images.

Modality
Radiotherapy Planning Imaging
Anatomy
CT anatomic locations and the prostate, seminal vesicles, and urethra on T2-weighted MR
Decision
2023-04-06
FDA-cleared K221680

Xeleris V Processing and Review System

GE Healthcare

Authorized purpose: The Xeleris V Processing and Review System displays, processes, archives, prints, reports, and networks planar, SPECT, and PET nuclear-medicine data, with optional applications for DaTQUANT, lung analysis, brain analysis, coronary-flow reserve, prostate-cancer bone metastases, liver shunt and dose calculations, and monitoring of patient radiation doses from nuclear-medicine imaging data.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, lung, brain, liver, cardiac, coronary, and other anatomy represented in labeled nuclear-medicine studies
Decision
2023-03-01
FDA-cleared K223439

SIGNA Victor

GE Healthcare (Tianjin) Company Limited

Authorized purpose: SIGNA Victor is a whole-body magnetic-resonance scanner for high-resolution imaging, high signal-to-noise ratio, and short scan times. It is indicated to produce axial, sagittal, coronal, and oblique images, spectroscopic images, parametric maps, spectra, and dynamic images of structures or functions of the entire body, including head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions. Contrast agents may be used depending on the region, and trained physicians interpret the images.

Modality
MRI
Anatomy
Entire body including head, neck, TMJ, spine, breast, heart, abdomen, pelvis, joints, prostate, blood vessels, and musculoskeletal regions
Decision
2023-02-13
FDA-cleared K222803

Oncospace

Oncospace, Inc.

Authorized purpose: Oncospace supports trained radiation therapy professionals with protocol configuration, machine-learning achievable-dose prediction, planning-objective exchange, and plan review for prostate and head-and-neck workflows using locked models.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2023-02-02
FDA-cleared K212783

ProstatID

ScanMed, LLC

Authorized purpose: Concurrent CADe/CADx reading aid for qualified physicians interpreting prostate MRI in adult males undergoing screening or clinical MRI, including high-risk screening or diagnostic imaging, to identify prostate abnormalities and regions suspicious for cancer and assess their likelihood of malignancy.

Modality
MRI
Anatomy
Prostate
Decision
2022-07-08
FDA-cleared K221106

Quantib Prostate

Quantib BV

Authorized purpose: Quantib Prostate versions 1.0 and 2.0 provide processing, visualization, editing, registration, mathematical or statistical analysis, semi-automatic segmentation, volume computation, and PI-RADS workflow support for prostate MRI. The software provides information that may assist trained medical professionals in interpreting prostate MR studies, and diagnosis must not be made solely from its analysis.

Modality
MRI
Anatomy
Prostate; prostate and prostatic sub-regions
Decision
2022-05-13
FDA-cleared K213976

Contour ProtégéAI

MIM Software Inc.

Authorized purpose: Contour ProtégéAI creates machine-learning contours from CT and MR DICOM images to support quantitative analysis, adaptive therapy, radiotherapy planning, archiving, and follow-up; professionals must visualize, review, and edit contours, and the software is not intended to detect or contour lesions.

Modality
Radiotherapy Planning Imaging
Anatomy
Normal structures in labeled CT locations; prostate, seminal vesicles, and urethra on T2 MR
Decision
2022-02-03
FDA-cleared K211655

aPROMISE

EXINI Diagnostics AB

Authorized purpose: aPROMISE is a cloud-based platform for healthcare professionals and researchers to accept, transfer, store, display, manipulate, quantify, and report PSMA PET/CT examinations using the PROMISE framework.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Prostate
Decision
2021-07-27
FDA-cleared K202284

Oncospace

Oncospace, Inc.

Authorized purpose: Oncospace supports trained radiation therapy professionals with protocol configuration, achievable-dose prediction, planning-objective exchange, and plan review for prostate, thoracic, pancreas, and head-and-neck workflows using locked models.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2021-03-12
FDA-cleared K203182

SubtleMR

Subtle Medical, Inc.

Authorized purpose: SubtleMR is MRI image-processing software for reducing noise in supported head, spine, neck, abdomen, pelvis, prostate, breast, and musculoskeletal MRI or increasing sharpness for head MRI within the labeled workflow.

Modality
MRI
Anatomy
Multi-region
Decision
2021-02-26
FDA-cleared K203582

QUIBIM Precision Prostate (qp-Prostate)

QUIBIM S.L.

Authorized purpose: Views, processes, and analyzes prostate MR images for trained professionals; it is not diagnostic and decisions should not rely solely on its results.

Modality
MRI
Anatomy
Prostate
Decision
2021-02-04
FDA-cleared K193306

PROView

GE Medical Systems SCS

Authorized purpose: PROView is an aiding tool for the clinicians to review multi-parametric prostate MR images following PI-RADS guidelines. It displays acquired and reformatted data for visualization and provides tools for assessment of the prostate gland volume and findings analysis in patients with known or suspected prostate lesions. Measurements and associated scoring are included in a report for communication to referring physicians.

Modality
MRI
Anatomy
Prostate
Decision
2020-11-17
FDA-cleared K202501

Quantib Prostate

Quantib BV

Authorized purpose: Quantib Prostate is image post-processing software for processing, visualizing, and editing prostate MRI images. It supports registered multiparametric-MRI viewing, optional combined-image visualization, semi-automatic anatomical segmentation, volume computation, manual editing, and a structured PI-RADS workflow to assist trained medical professionals interpreting prostate MR studies; diagnosis should not be made solely from its analysis.

Modality
MRI
Anatomy
Prostate
Decision
2020-10-11
FDA-cleared K193283

AI-Rad Companion Prostate MR

Siemens Medical Solutions USA Inc.

Authorized purpose: Assists clinicians in viewing, manipulating, analyzing, and evaluating prostate MR images for US-guided MR-US fusion biopsy support.

Modality
MRI
Anatomy
Prostate
Decision
2020-07-30
FDA-cleared K193252

Contour ProtegeAI

MIM Software Inc.

Authorized purpose: Contour ProtegeAI is used by trained medical professionals as a tool for automated processing of CT and MR medical images. It creates contours with machine-learning algorithms for quantitative analysis, adaptive therapy support, transfer to radiation-treatment planning systems, and archiving, segments normal structures across CT anatomical locations, and segments the prostate, seminal vesicles, and urethra in T2-weighted MR images. It must be used with MIM software to review and, if necessary, edit automatically generated contours.

Modality
Radiotherapy Planning Imaging
Anatomy
Normal structures in CT anatomy; prostate, seminal vesicles, and urethra on T2-weighted MR
Decision
2020-07-02
FDA-cleared K191278

RSI-MRI+

MultiModal Imaging Services Corporation (dba HealthLytix)

Authorized purpose: RSI-MRI+ is indicated for use as automatic post-acquisition image processing software for analysis of diffusion-weighted and anatomical magnetic resonance imaging data. RSI-MRI+ is intended for automatic fusion of derived diffusion-weighted MRI data with anatomical T2-weighted MR images. RSI-MRI+ is additionally intended to provide automatic prostate segmentation, quantification, and reporting of derived image metrics.

Modality
MRI
Anatomy
Prostate
Decision
2019-11-19
FDA-cleared K170250

SmartTarget

SmartTarget, Ltd.

Authorized purpose: SmartTarget is an accessory for image-guided interventional and diagnostic prostate procedures that enhances two-dimensional transrectal ultrasound, reconstructs three-dimensional ultrasound, and displays multiplanar views, annotations, and instrument location for procedures such as biopsy, ablation, and brachytherapy.

Modality
Ultrasound
Anatomy
Prostate
Decision
2017-06-07